Lidocaine /ml

Phase 3Small molecule

UUniversity Health Network, Toronto

Lidocaine /ml is one of 54 small molecule programs targeting Post-mastectomy Pain Syndrome. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Post-Mastectomy Pain SyndromeRecruiting

TinnitusActive, not recruiting

AcupunctureCompleted

StrokeRecruiting

Post-Mastectomy Pain SyndromePhase 3

Recruiting

TinnitusPreclinical

Active, not recruiting

AcupuncturePreclinical

Completed

StrokePhase 3

Recruiting

Competition

Competitive Landscape

150 competitors in Stroke

#DrugCompanyPhaseTrials

Lidocaine /ml

UUniversity Health Network, Toronto

Phase 3

1 2

Zometa

Pfizer

Preclinical

1 3

Savella

AbbVie

Preclinical

1 4

Proamatine

Repatha

Zantac 150

1 7

Periactin

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Preclinical

1 8

Alka-Seltzer

AAbbott

Preclinical

1 9

Haldol

DDePuy Orthopaedics

Preclinical

1 10

Inderal

Mylan Pharmaceuticals Inc

Preclinical

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

Phase 3Recruiting

Post-Mastectomy Pain Syndrome

NCT04874038

Q1 2027

Phase 3Recruiting

Stroke

NCT06446960

Q1 2029

N/ARecruiting

Local Anesthetic

NCT06602349

Clinical

Trials by Indication[1]

Stroke1 trial

The Role of Peripheral Afferents in Modulating Post-stroke Central Pain

Recruiting·IInstitut National de la Santé Et de la Recherche Médicale, France·Phase 3·NCT06446960·36 enrolled

Chronic Post-surgical Pain1 trial

Intravenous Lidocaine in Carcinologic ENT Surgery: A Trial for Evaluation of Opioid Saving Strategy and Chronic Post-surgical Pain (ELICO)

Completed·HHospices Civils de Lyon·Phase 3·NCT02894710·143 enrolled

Tinnitus1 trial

Action of Intra-auricular Topical Lidocaine on Tinnitus

Completed·UUniversity of Sao Paulo General Hospital·N/A·NCT05711641·32 enrolled

Analgesia1 trial

Impact of Intra- and Postoperative Continuous Infusion of Lidocaine on Analgesia in Vascular Anaesthesia

Completed·ŁŁukasz Krzych·Phase 4·NCT04691726·87 enrolled

Local Anesthetic1 trial

EFFICACY of USUAL MANAGEMENT of CHRONIC IDIOPATHIC ANO-PERINEAL PAIN by USING LOCAL ANESTHETIC INFILTRATION

Recruiting·GGroupe Hospitalier Diaconesses Croix Saint-Simon·N/A·NCT06602349·60 enrolled

2 more indications

Acupuncture1 trial

Acupuncture for Pain Relief During Perineal Repair After Childbirth

Completed·SSonderborg Hospital·N/A·NCT00328796·207 enrolled

Post-mastectomy Pain Syndrome1 trial

Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)

Recruiting·UUniversity Health Network, Toronto·Phase 3·NCT04874038·1,602 enrolled

Sources

References

[1]
ClinicalTrials.gov — 7 trial records for Lidocaine /ml. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Lidocaine /ml compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Lidocaine /ml. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University Health Network, Toronto company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: UUniversity Health Network, Toronto

Lidocaine /ml

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2026

Q1 2027

Q1 2029

Trials by Indication[1]

Stroke1 trial

Chronic Post-surgical Pain1 trial

Tinnitus1 trial

Analgesia1 trial

Local Anesthetic1 trial

Acupuncture1 trial

Post-mastectomy Pain Syndrome1 trial

References

Drug Info

Quick Facts

Related News